Literature DB >> 15014735

Clinical Dimensions of Fatigue.

Donna B. Greenberg1.   

Abstract

Because the symptom of fatigue is often vague, clinical evaluation requires the consideration of distinct features such as timing, precipitants, presence of libido, sleep quality, exercise capacity, and sedation. Fatigue has dimensions of affect and tolerability. In chronic illness, it is helpful to consider mood, physical conditioning, course of predictable treatment consequences, postural hypotension, and the well-being of caretakers. The differential diagnosis of acute and chronic fatigue is considered. Chronic fatigue of unknown etiology is placed in historical context, and an approach to the complexities of providing continuing evaluation and care is discussed.

Entities:  

Year:  2002        PMID: 15014735      PMCID: PMC181235          DOI: 10.4088/pcc.v04n0301

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  22 in total

1.  Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study.

Authors:  A Deale; K Husain; T Chalder; S Wessely
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

Review 2.  Fatigue in the chronic fatigue syndrome: a cognitive phenomenon?

Authors:  A M Fry; M Martin
Journal:  J Psychosom Res       Date:  1996-11       Impact factor: 3.006

Review 3.  Biological basis of the behavior of sick animals.

Authors:  B L Hart
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

4.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

5.  Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.

Authors:  A Deale; T Chalder; I Marks; S Wessely
Journal:  Am J Psychiatry       Date:  1997-03       Impact factor: 18.112

6.  Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.

Authors:  J B Prins; G Bleijenberg; E Bazelmans; L D Elving; T M de Boo; J L Severens; G J van der Wilt; P Spinhoven; J W van der Meer
Journal:  Lancet       Date:  2001-03-17       Impact factor: 79.321

7.  Psychiatric disorders and medical care utilization among people in the general population who report fatigue.

Authors:  E A Walker; W J Katon; R P Jemelka
Journal:  J Gen Intern Med       Date:  1993-08       Impact factor: 5.128

Review 8.  The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review.

Authors:  J Joyce; M Hotopf; S Wessely
Journal:  QJM       Date:  1997-03

9.  Psychiatric and medical factors associated with disability in patients with dizziness.

Authors:  M R Clark; M D Sullivan; W J Katon; J E Russo; M Fischl; R A Dobie; R Voorhees
Journal:  Psychosomatics       Date:  1993 Sep-Oct       Impact factor: 2.386

Review 10.  Chronic fatigue syndrome. Summary of a report of a joint committee of the Royal Colleges of Physicians, Psychiatrists and General Practitioners.

Authors:  S Wessely
Journal:  J R Coll Physicians Lond       Date:  1996 Nov-Dec
View more
  3 in total

1.  What do patients with medically unexplained physical symptoms (MUPS) think? A qualitative study.

Authors:  José Nunes; Teresa Ventura; Ricardo Encarnação; Patrícia Rosado Pinto; Isabel Santos
Journal:  Ment Health Fam Med       Date:  2013-06

Review 2.  A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD.

Authors:  Maureen Metzger; Emaad M Abdel-Rahman; Heather Boykin; Mi-Kyung Song
Journal:  Kidney Int Rep       Date:  2021-02-10

3.  Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.

Authors:  Adonis Sfera; Carolina Osorio; Carlos M Zapata Martín Del Campo; Shaniah Pereida; Steve Maurer; Jose Campo Maldonado; Zisis Kozlakidis
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.